| 摘要 |
Dear Editor, the publication on “Prophylactic antibiotics
and percutaneous nephrolithotomy (PCNL)” by Yang et al. is
very interesting.[1] Yang et al. concluded that “The second‑line
prophylactic antibiotic use for tubeless PCNL does not offer
additional benefit over the first‑line prophylactic antibiotic in
the prevention of postoperative fever or shortening of the
postoperative hospital stay.[1]” In fact, the use of either first‑ or
second‑line prophylaxis antibiotic is usually a controversial issue
in surgical infection control. As noted by Lai and Assimos,
“despite prophylaxis, postoperative sepsis has continued to
remain the leading cause of mortality in PCNL patients.[2]”
In addition, the common forgotten issue is on the possible
adverse effect due to antibiotic use. As suggested by Viers et al.,
“counseling patients on the risks of perioperative antimicrobial
therapy at PCNL” is needed.[3] Finally, Yang et al. might focus
only on the hospital stay but forget other dimensions (such as
surgical‑ and drug‑related complication, quality of life, patient
and cousin acceptance, and cost of the prophylaxis). |
